21 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
and developing highly skilled talent and invests in creating a diverse, equitable and inclusive workplace that supports employees’ flexible ways
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
prioritizes attracting and developing highly skilled talent and invests in creating a diverse, equitable and inclusive workplace that supports employees
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
17 Dec 20
Current report (foreign)
6:01am
is used for water heating; providing reliable light after sunset that allows more time for work and school; and creating over 300 skilled jobs … -in-class, we must attract diverse and highly skilled business leaders to serve on our Board of Directors. Compensation for our directors must be competitive
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
P E O P L E Attract and develop highly skilled talent and invest in creating a diverse, equitable and inclusive workplace that supports our staff’s
20FR12B
EX-10.1
TAK
Takeda Pharmaceutical Co
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
a skilled and experienced person engaged in the same type of undertaking under the same or similar circumstances). Notwithstanding the foregoing, a Party
DRS/A
EX-10.1
2ipq9 8z0e7a
16 Nov 18
Draft registration statement (amended)
12:00am
6-K
EX-99.1
rg14rk8
29 Jun 21
Current report (foreign)
7:38am
20FR12B/A
939ao w6vysbda6b7
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20-F
ffct4glm
27 Jun 19
Annual report (foreign)
6:41am
DRS/A
van4 e26mgvaa8m
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
orp57n0t8
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
F-4/A
hnps7jd y4baav
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
20FR12B/A
EX-10.1
7kqne92xhmmtb eo0
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
F-4
t21 7vl5fzxr62wus6p
9 Aug 19
Registration of securities (foreign)
6:27am
6-K
EX-99.1
qat2zvd86sznstp
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
uu2l z316j3evard
14 Nov 19
Prospectus supplement
6:10am